1h Free Analyst Time
The publisher has been monitoring the foot and mouth disease vaccines market and it is poised to grow by $ 1.08 bn during 2021-2025, progressing at a CAGR of 8.81% during the forecast period. The report on the foot and mouth disease vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in government initiatives and frequent FMD outbreaks in Asia and the Middle East.
The foot and mouth disease vaccines market analysis includes the product segment and geographic landscape.
The foot and mouth disease vaccines market is segmented as below:
By Product
- Conventional vaccines
- Emergency vaccines
By Geographical Landscape
- Asia
- Europe
- North America
- ROW
This study identifies the increase in demand for livestock products as one of the prime reasons driving the foot and mouth disease vaccines market growth during the next few years.
The report on foot and mouth disease vaccines market covers the following areas:
- Foot and mouth disease vaccines market sizing
- Foot and mouth disease vaccines market forecast
- Foot and mouth disease vaccines market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading foot and mouth disease vaccines market vendors that include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Indian Immunologicals Ltd., Inovio Pharmaceuticals Inc., Merck & Co. Inc., SEPPIC SA, VECOL SA, and VETAL Animal Health Products Inc. Also, the foot and mouth disease vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Conventional vaccines - Market size and forecast 2020-2025
- Emergency vaccines - Market size and forecast 2020-2025
- Market opportunity by Product
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- Asia - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- North America - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Biogenesis Bago SA
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Indian Immunologicals Ltd.
- Inovio Pharmaceuticals Inc.
- Merck & Co. Inc.
- SEPPIC SA
- VECOL SA
- VETAL Animal Health Products Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Product - Market share 2020-2025 (%)
- Comparison by Product
- Conventional vaccines - Market size and forecast 2020-2025 ($ million)
- Conventional vaccines - Year-over-year growth 2020-2025 (%)
- Emergency vaccines - Market size and forecast 2020-2025 ($ million)
- Emergency vaccines - Year-over-year growth 2020-2025 (%)
- Market opportunity by Product
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Biogenesis Bago SA - Overview
- Biogenesis Bago SA - Product and service
- Biogenesis Bago SA - Key offerings
- Biogenesis Bago SA - Key customers
- Biogenesis Bago SA - Segment focus
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Business segments
- Boehringer Ingelheim International GmbH - Key offerings
- Boehringer Ingelheim International GmbH - Key customers
- Boehringer Ingelheim International GmbH - Segment focus
- Ceva Sante Animale - Overview
- Ceva Sante Animale - Product and service
- Ceva Sante Animale - Key offerings
- Ceva Sante Animale - Key customers
- Ceva Sante Animale - Segment focus
- Indian Immunologicals Ltd. - Overview
- Indian Immunologicals Ltd. - Product and service
- Indian Immunologicals Ltd. - Key offerings
- Indian Immunologicals Ltd. - Key customers
- Indian Immunologicals Ltd. - Segment focus
- Inovio Pharmaceuticals Inc. - Overview
- Inovio Pharmaceuticals Inc. - Product and service
- Inovio Pharmaceuticals Inc. - Key offerings
- Inovio Pharmaceuticals Inc. - Key customers
- Inovio Pharmaceuticals Inc. - Segment focus
- Merck & Co. Inc. - Overview
- Merck & Co. Inc. - Business segments
- Merck & Co. Inc. - Key offerings
- Merck & Co. Inc. - Key customers
- Merck & Co. Inc. - Segment focus
- SEPPIC SA - Overview
- SEPPIC SA - Product and service
- SEPPIC SA - Key offerings
- SEPPIC SA - Key customers
- SEPPIC SA - Segment focus
- VECOL SA - Overview
- VECOL SA - Product and service
- VECOL SA - Key offerings
- VECOL SA - Key customers
- VECOL SA - Segment focus
- VETAL Animal Health Products Inc. - Overview
- VETAL Animal Health Products Inc. - Product and service
- VETAL Animal Health Products Inc. - Key offerings
- VETAL Animal Health Products Inc. - Key customers
- VETAL Animal Health Products Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global foot and mouth disease vaccines market: Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Indian Immunologicals Ltd., Inovio Pharmaceuticals Inc., Merck & Co. Inc., SEPPIC SA, VECOL SA, and VETAL Animal Health Products Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increase in demand for livestock products.`
According to the report, one of the major drivers for this market is the increase in government initiatives.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biogenesis Bago SA
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Indian Immunologicals Ltd.
- Inovio Pharmaceuticals Inc.
- Merck & Co. Inc.
- SEPPIC SA
- VECOL SA
- VETAL Animal Health Products Inc.
